+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)

Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health. 

Any NephU member can request a presentation for their region or organization at no charge.

Featured Events

Events

Increasing Awareness Of Autosomal Dominant Polycystic Kidney Disease (ADPKD) In Underrepresented & Underserved Communities

Commander's Palace 1403 Washington Ave, New Orleans, Louisiana, United States

This presentation focuses on the impact of kidney disease and autosomal dominant polycystic kidney disease (ADPKD) in Black and Hispanic/Latino communities and the effects of social determinants of health on patients living with kidney. Diagnosing and managing the care of patients living with ADPKD will also be discussed.

Factors Influencing Drug Dialyzability

In this webinar, the speakers will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.

Genetic Testing in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

The Establishment 28 Broad St, Charleston, SC, United States

In this presentation, the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and the various types of molecular genetic tests available will be discussed.

How Radiologic Technologists Impact the Diagnosis & Prognosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease (ADPKD), an inherited progressive kidney disease, is the fourth leading cause of kidney failure in the US. ADPKD has a spectrum of clinical and imaging features that have direct prognostic implications1. Total kidney volume (TKV), adjusted for height and age, has been shown to be the best predictor of kidney function decline; this forms the basis for the Mayo Clinic Imaging Classification (MCIC) of the severity grade of ADPKD1. Radiology’s central role in ADPKD is to aid in the imaging-based diagnosis, prognostication, and monitoring for disease progression.